ZMYM2
Basic information
Region (hg38): 13:19958677-20091829
Previous symbols: [ "ZNF198" ]
Links
Phenotypes
GenCC
Source:
- congenital anomaly of kidney and urinary tract (Strong), mode of inheritance: AD
- congenital anomaly of kidney and urinary tract (Moderate), mode of inheritance: AD
- neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities (Strong), mode of inheritance: AD
- neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities (Strong), mode of inheritance: AD
- neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities | AD | Cardiovascular; Renal | Among other findings, individuals may have congenital cardiovascular and renal anomalies, which may lead to sequelae, and awareness may allow prompt diagnosis and medical or surgical management | Cardiovascular; Craniofacial; Genitourinary; Musculoskeletal; Neurologic; Renal | 32891193 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (135 variants)
- Inborn_genetic_diseases (117 variants)
- Neurodevelopmental-craniofacial_syndrome_with_variable_renal_and_cardiac_abnormalities (57 variants)
- ZMYM2-related_disorder (30 variants)
- Congenital_anomaly_of_kidney_and_urinary_tract (15 variants)
- not_specified (12 variants)
- Neurodevelopmental_disorder (4 variants)
- See_cases (3 variants)
- Combined_oxidative_phosphorylation_deficiency_40 (2 variants)
- ZMYM2-related_neurodevelopmental_disorder_with_multiple_anomalies (1 variants)
- Neurodevelopmental_delay (1 variants)
- Seizure (1 variants)
- Neurodevelopmental_abnormality (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ZMYM2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000197968.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 10 | 15 | ||||
| missense | 194 | 202 | ||||
| nonsense | 12 | 24 | 39 | |||
| start loss | 0 | |||||
| frameshift | 26 | 22 | 55 | |||
| splice donor/acceptor (+/-2bp) | 12 | |||||
| Total | 39 | 54 | 208 | 17 | 5 |
Highest pathogenic variant AF is 0.00008718806
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| ZMYM2 | protein_coding | protein_coding | ENST00000382869 | 23 | 133159 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.666 | 0.334 | 125671 | 0 | 25 | 125696 | 0.0000995 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 3.01 | 451 | 671 | 0.672 | 0.0000324 | 9073 |
| Missense in Polyphen | 109 | 257.93 | 0.4226 | 3605 | ||
| Synonymous | 1.17 | 211 | 234 | 0.903 | 0.0000119 | 2483 |
| Loss of Function | 6.06 | 15 | 69.5 | 0.216 | 0.00000395 | 895 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000295 | 0.000289 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.0000473 | 0.0000462 |
| European (Non-Finnish) | 0.000153 | 0.000149 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May function as a transcription factor.;
- Disease
- DISEASE: Note=A chromosomal aberration involving ZMYM2 may be a cause of stem cell leukemia lymphoma syndrome (SCLL). Translocation t(8;13)(p11;q12) with FGFR1. SCLL usually presents as lymphoblastic lymphoma in association with a myeloproliferative disorder, often accompanied by pronounced peripheral eosinophilia and/or prominent eosinophilic infiltrates in the affected bone marrow. {ECO:0000269|PubMed:9716603}.;
- Pathway
- Disease;Signaling by FGFR in disease;Signaling by cytosolic FGFR1 fusion mutants;FGFR1 mutant receptor activation;Signaling by FGFR1 in disease;Diseases of signal transduction
(Consensus)
Recessive Scores
- pRec
- 0.210
Intolerance Scores
- loftool
- 0.773
- rvis_EVS
- -1.28
- rvis_percentile_EVS
- 5.11
Haploinsufficiency Scores
- pHI
- 0.784
- hipred
- Y
- hipred_score
- 0.627
- ghis
- 0.661
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.951
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Zmym2
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- regulation of transcription by RNA polymerase II;biological_process;peptidyl-tyrosine phosphorylation;regulation of cell morphogenesis
- Cellular component
- nucleus;cytosol;PML body
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;protein tyrosine kinase activity;protein binding;zinc ion binding;ubiquitin conjugating enzyme binding